HSP90AB1 and non-small cell lung carcinoma: HDAC inhibitor depsipeptide (Romidepsin) induced acetylation of HSP90 and destabilized HSP90 interaction with several clients, including ErbB2, Raf-1, and mutant p53 in in non-small cell lung cancer cells (32).